A study for a 59 year old woman who takes Eliquis, Montelukast Sodium, Vyvanse (an AI-powered real world drug study)

---

---

Number of reports submitted per year:

Information of the patient in this study:

• Age: 59
• Gender: female
• Conditions: Pulmonary Embolism, Allergies, Binge Eating
• Drugs taken:
  • Eliquis (apixaban)
  • Montelukast Sodium (montelukast sodium)
  • Vyvanse (lisdexamfetamine dimesylate)

---

Comparison with patient's specific adverse outcomes:

You can check what is more associated with an adverse outcome: a drug mix, a drug, a condition, or a population of certain gender and age. Each patient is different. It is not uncommon that the results can be inconclusive or insignificant.

By the same drug(s):

• Raynaud's Phenomenon (discoloration of the fingers, toes, and occasionally other areas):
  - among females aged 59 (±5) who take the same drugs: 0% (0 of 843)
  - among people who take the same drugs, regardless of gender or age: 0% (0 of 6,571)
• Dry Mouth:
  - among females aged 59 (±5) who take the same drugs: 0.36% (3 of 843)
  - among people who take the same drugs, regardless of gender or age: 0.05% (3 of 6,571)

By each condition:

• people who have Dry Mouth with Pulmonary Embolism:
  - among females aged 59 (±5) who have Pulmonary Embolism: 0.16% (5 of 3,110)
  - among people who have Pulmonary Embolism, regardless of gender or age: 0.72% (260 of 36,120)
• people who have Dry Mouth with Allergies:
  - among females aged 59 (±5) who have Allergies: 0.27% (1 of 374)
  - among people who have Allergies, regardless of gender or age: 0.19% (7 of 3,731)
• people who have Dry Mouth with Binge Eating:
  - among females aged 59 (±5) who have Binge Eating: 4.44% (2 of 45)
  - among people who have Binge Eating, regardless of gender or age: 2.2% (15 of 682)
• people who have Raynaud's Phenomenon with Pulmonary Embolism:
  - among females aged 59 (±5) who have Pulmonary Embolism: 0% (0 of 3,110)
  - among people who have Pulmonary Embolism, regardless of gender or age: 0.01% (2 of 36,120)
• people who have Raynaud's Phenomenon with Allergies:
  - among females aged 59 (±5) who have Allergies: 0% (0 of 374)
  - among people who have Allergies, regardless of gender or age: 0% (0 of 3,731)
• people who have Raynaud's Phenomenon with Binge Eating:
  - among females aged 59 (±5) who have Binge Eating: 4.44% (2 of 45)
  - among people who have Binge Eating, regardless of gender or age: 0.59% (4 of 682)

By each drug (FDA data only):

• people who take Eliquis and have Dry Mouth:
  - among females aged 59 (±5) who take Eliquis and have side effects: 0.75% (59 of 7,851)
  - among people who take Eliquis and have side effects, regardless of gender or age: 0.39% (745 of 189,426)
• people who take Montelukast Sodium and have Dry Mouth:
  - among females aged 59 (±5) who take Montelukast Sodium and have side effects: 0.56% (18 of 3,205)
  - among people who take Montelukast Sodium and have side effects, regardless of gender or age: 0.63% (155 of 24,782)
• people who take Vyvanse and have Dry Mouth:
  - among females aged 59 (±5) who take Vyvanse and have side effects: 1.94% (18 of 929)
  - among people who take Vyvanse and have side effects, regardless of gender or age: 1.33% (373 of 28,085)
• people who take Eliquis and have Raynaud's Phenomenon:
  - among females aged 59 (±5) who take Eliquis and have side effects: 0.11% (9 of 7,851)
  - among people who take Eliquis and have side effects, regardless of gender or age: 0.03% (58 of 189,426)
• people who take Montelukast Sodium and have Raynaud's Phenomenon:
  - among females aged 59 (±5) who take Montelukast Sodium and have side effects: 0.06% (2 of 3,205)
  - among people who take Montelukast Sodium and have side effects, regardless of gender or age: 0.05% (12 of 24,782)
• people who take Vyvanse and have Raynaud's Phenomenon:
  - among females aged 59 (±5) who take Vyvanse and have side effects: 0.86% (8 of 929)
  - among people who take Vyvanse and have side effects, regardless of gender or age: 0.51% (144 of 28,085)

Common drug interactions *:

1. Headache (pain in head): 442 people, 52.43%
2. High Blood Pressure : 404 people, 47.92%
3. Cardiac Disorder : 395 people, 46.86%
4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 395 people, 46.86%
5. Sleep Disorder : 394 people, 46.74%
6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 392 people, 46.50%
7. Burning Sensation : 390 people, 46.26%
8. Fibromyalgia (a long-term condition which causes pain all over the body): 390 people, 46.26%
9. Carpal Tunnel Syndrome (nerve compression at wrist results numbness weakness, pain , swelling): 387 people, 45.91%
10. Sensitisation (the state of being sensitive): 387 people, 45.91%
11. Sleep Apnea Syndrome : 385 people, 45.67%
12. Polycystic Ovary Disease (cysts in the ovaries that occurs when the follicle stops developing): 385 people, 45.67%
13. Blood Test Abnormal : 383 people, 45.43%
14. Dyspnea (difficult or laboured breathing): 351 people, 41.64%
15. Ejection Fraction (the percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat): 322 people, 38.20%
16. Renal Disorder (kidney disease): 315 people, 37.37%
17. Wheezing (a high-pitched whistling sound made while you breath): 306 people, 36.30%
18. Hospitalisation : 172 people, 20.40%
19. Ejection Fraction Abnormal (abnormality in percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat): 142 people, 16.84%
20. Adverse Event : 122 people, 14.47%

Common co-existing conditions *:

You may use this to check any potential undetected conditions.

1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 39 people, 4.63%
2. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 35 people, 4.15%
3. Pain : 34 people, 4.03%
4. Multiple Myeloma (cancer of the plasma cells): 31 people, 3.68%
5. Stress And Anxiety : 28 people, 3.32%
6. High Blood Pressure : 25 people, 2.97%
7. Immunodeficiency Common Variable : 23 people, 2.73%
8. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 22 people, 2.61%
9. Hypersensitivity : 21 people, 2.49%
10. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 17 people, 2.02%
11. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 17 people, 2.02%
12. High Blood Cholesterol : 17 people, 2.02%
13. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 16 people, 1.90%
14. Dyspnea (difficult or laboured breathing): 15 people, 1.78%
15. Muscle Spasms (muscle contraction): 15 people, 1.78%
16. Nausea (feeling of having an urge to vomit): 14 people, 1.66%
17. Pulmonary Hypertension (increase in blood pressure in the lung artery): 14 people, 1.66%
18. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 13 people, 1.54%
19. Seasonal Allergy (allergic condition due to certain season): 12 people, 1.42%
20. Arthritis (form of joint disorder that involves inflammation of one or more joints): 12 people, 1.42%

Common co-used drugs *:

You may use this to check any potential interacting drugs.

1. Prednisone (377 people, 44.72%)
2. Nasonex (377 people, 44.72%)
3. Clonazepam (333 people, 39.50%)
4. Albuterol (332 people, 39.38%)
5. Vitamin C (315 people, 37.37%)
6. Spironolactone (314 people, 37.25%)
7. Liothyronine Sodium (308 people, 36.54%)
8. Levothyroxine Sodium (288 people, 34.16%)
9. Cyanocobalamin (283 people, 33.57%)
10. Ergocalciferol (247 people, 29.30%)
11. Esomeprazole Magnesium (222 people, 26.33%)
12. Vitamin B12 (220 people, 26.10%)
13. Acyclovir (215 people, 25.50%)
14. Tramadol (204 people, 24.20%)
15. Tramadol Hydrochloride (198 people, 23.49%)
16. Ventolin (196 people, 23.25%)
17. Budesonide (186 people, 22.06%)
18. Albuterol Sulfate (184 people, 21.83%)
19. Vitamin D3 (177 people, 21.00%)
20. Sodium Bicarbonate (177 people, 21.00%)

Drug effectiveness *:

---